Standout Papers
- Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy (2006)
- Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD (2014)
- Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration (2006)
Immediate Impact
1 by Nobel laureates 1 from Science/Nature 84 standout
Citing Papers
Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
2024 Standout
Works of Ma'an Nasir being referenced
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
2006 Standout
Intravitreal Bevacizumab (Avastin) in the Treatment of Proliferative Diabetic Retinopathy
2006 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ma'an Nasir | 2350 | 1830 | 188 | 436 | 24 | 2.6k | |
| Melvin Rabena | 2232 | 1741 | 128 | 448 | 17 | 2.5k | |
| Alessandro Castellarin | 2830 | 2097 | 215 | 513 | 40 | 3.1k | |
| Atsushi Minamoto | 1297 | 1314 | 191 | 398 | 40 | 2.0k | |
| Michael J. Cooney | 3251 | 2192 | 289 | 433 | 40 | 3.8k | |
| Lutz L. Hansen | 1757 | 1152 | 149 | 409 | 38 | 2.2k | |
| Scott M. Friedman | 3161 | 2568 | 78 | 364 | 47 | 3.5k | |
| H. Michael Lambert | 1535 | 1047 | 138 | 649 | 35 | 1.9k | |
| Kazuaki Nishijima | 2152 | 1571 | 92 | 648 | 50 | 2.6k | |
| Catherine Meyerle | 2799 | 1808 | 139 | 515 | 49 | 3.0k | |
| Anne E. Fung | 3043 | 2328 | 109 | 331 | 36 | 3.2k |
All Works
Loading papers...